Journal of Cancer Research and Therapeutics

ERRATUM
Year
: 2018  |  Volume : 14  |  Issue : 2  |  Page : 478-

Erratum: Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy


 

Correspondence Address:




How to cite this article:
. Erratum: Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy.J Can Res Ther 2018;14:478-478


How to cite this URL:
. Erratum: Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy. J Can Res Ther [serial online] 2018 [cited 2020 Jun 3 ];14:478-478
Available from: http://www.cancerjournal.net/text.asp?2018/14/2/478/226733


Full Text



In the article titled, “Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy”, DOI 10.4103/0973-1482.183550 of Journal of Cancer Research and Therapeutics,[1] the affiliation of author Nooshin Banaee is written incorrectly as “Department of Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran” instead of “Department of Medical Radiation Engineering, Central Tehran Branch, Islamic Azad University, Tehran, Iran.”

References

1Khezerloo D, Nedaie HA, Takavar A, Zirak A, Farhood B, Banaee N, Alidokht E Dosimetric properties of new formulation of PRESAGE® with tin organometal catalyst: Development of sensitivity and stability to megavoltage energy. J Can Res Ther 2016. [DOI: 10.4103/0973-1482.183550]. [Epub ahead of print].